Ambirix (hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Ambirix suspension for injection in pre-filled syringe

Ambirix is indicated in non-immune children and adolescents from 1 year up to and including 15 years of age for protection against hepatitis A and hepatitis B infection.

Protection against hepatitis B infections may not be obtained until after the second dose.

Therefore:

- Ambirix should be used only when there is a relatively low risk of hepatitis B infection during the vaccination course.

- It is recommended that Ambirix should be administered in settings where completion of the two-dose vaccination course can be assured.


Route of administration: Injectable
Molecule: hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)

Patients' opinions on Ambirix

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.